Interleukin-6 concentration serum and cerebrospinal fluid multiple sclerosis patients

Medical Science Monitor

Volumn 6, Issue 6, 2000, Pages 1104-1108

  Stelmasiak, Z ^a   Koziol Montewka, M ^a   Dobosz, B ^a   Rejdak, K ^a   Bartosik Psujek, H ^a   Mitosek Szewczyk, K ^a   Belniak Legiec E ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

CSF; Interleukin 6 serum; Multiple sclerosis

Indexed keywords

INTERLEUKIN 6;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISABILITY; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; SERUM;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS;

EID: 0034528814     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Immune-mediated demyelination
2. Cytokine production by peripheral blood monocytes/macrophages in multiple sclerosis patients
3. Cytokine networks in multiple sclerosis
4. Increased production of interferongamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis
5. Prospective serial analysis of interleukin-2 and soluble interleukin-2 receptor in relapsing-remitting multiple sclerosis
6. Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression
7. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with down-regulation of inflammatory cytokines and differential upregulation of TGF-β, IL-4 and PGE expression in the brain
8. Cytokines and growth fators
9. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies
10. Anti-myelin basic protein and anti-proteolipid protein specific forms of multiple sclerosis
11. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin
12. Interleukin-6 in biology and medicine
13. IL-6 as an anti-inflammatory cytokine: Induction of circulating IL-1 receptor antagonist and soluble TNF receptor p55
14. Transient increase in symptoms associated with cytokine release in patients with MS
15. TNF inhibition and sepsis-sounding a cautionary note
16. Protective effect of anti-interleukin (IL)-6 antibody against endotoxin, associated with paradoxically increased IL-6 levels
17. Cladribine in treatment of chronic progressive multiple sclerosis
18. Leczenie stwardnienia rozsianego przy pomocy nowego immunosupresanta kladribiny (2-CdA)
19. Increased IL-6 mRNA expression in blood and CNS mononuclear cells in MS
20. Interleukin-6 is elevated in plasma in multiple sclerosis